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Mutants  of  several  pneumococcal types have been  described  which  form 
smaller  amounts  of  capsular  polysaccharides  than  the  parent  or  normally 
encapsulated strain from which they derived.  S transforming principles from 
these mutants  confer on certain R  strains of pneumococcus the  capacity to 
produce amounts of polysaccharide characteristic of the S mutants. It has been 
suggested  that  the  transforming principles  of strains  showing differences  in 
polysaccharide synthesis bear a  relation to each other similar  to that of the 
genes  of  an  allelic  series  (1-3). 
In  discussing  the  mechanisms  involved  in  differences  in  polysaccharide 
formation it was suggested earlier  (1)  that variation might depend not only 
on  "atlelic"  differences  in  the  S  transforming  principles  but  also  on  some 
other  system  in  the  cell  capable  of  modifying polysaccharide  production. 
The present paper is concerned with  the demonstration that polysaccharide 
formation  can  be  modified  by  factors  distinct  from  the  S  transforming 
principle. It has been shown that encapsulated pneumococci may possess and 
reduplicate normal S transforming principle and yet produce much less poly- 
saccharide than would be expected if the nature of the S transforming prin- 
ciple were the sole  determinant. 
Materials and Methods 
Transformation Reavtions.--The preparation of the transforming extracts and  the tech- 
nique for carrying out the reactions were the same as described previously (1). 
Strains of Pncumococci.--Type I strain 519/43/41  ° and R variants derived from it: Type 
I strain 519/43/41  ° was obtained originally by Dr. Robert Austrian from Dr. Ema M~rch- 
Lund of the State Serum Institute in Copenhagen. It had been transferred for 300 subcultures 
in serum broth at 41°C. in Dr. MCrch-Lund's  laboratory and was reported (4) to have lost 
its power to ferment salicin within an incubation period of 24 hours, though its other fer- 
mentative capacities were unchanged. Five R variants were selected from strain I]519/43/41" 
by Dr. Austrian after 6 serial subcultures in broth containing type I antiserum. Cultures of 
the R variants were streaked on blood agar plates in this laboratory and a number of single 
colonies picked and transferred to broth for use in transformation reactions. Two of these 
R strains are referred to in the present paper as I-R6 and I-R7. 
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II-R36NC: A colonial variant of the R strain, R36, used in previous studies (1, 3). R36 
was derived originally from type II strain D39S. 
IILA66S:  A fully encapsulated,  "normal" strain  of pneumococcus type III which has 
been used extensively in transformation  studies. 
Measurement of Capsular Polysaccharide.--Type III  pneumococci were incubated  in 
neopeptone-meat infusion broth at 37°C. for 8 hours and then placed in an ice bath to stop 
growth. Samples were removed for measurement of the viable count, bacterial nitrogen per 
milliliter, and the amount of capsular polysaccharide (Sill) per milliliter. An incubation time 
of 8 hours was chosen to avoid autolysis which would interfere with all of the above measure- 
ments except that of SlII. 
The viable count was determined by using poured blood agar plates containing appropriate 
dilutions of the cultures. 
Bacterial  nitrogen was measured by micro Kjeldahl  technique. The broth culture  was 
heated  at 65°C. for 30 minutes in a water bath to prevent autolysis, the pneumococci sedi- 
mented by centrifrigation, and then washed three times in saline before digestion. 
For measurement of SlII production an aliquot of unheated broth culture was lysed by 
addition of sodium desoxycholate in a final concentration of 0.05 per cent. Complete clearing 
of the bacterial suspension occurred within 5 to 10 minutes at room temperature.  SlII was 
estimated photometrically by measuring the absorption caused by antigen-antibody precipi- 
tates in the presence of excess antibody according to the technique of Bernheimer (5). To 
0.5 ml. of an appropriate  dilution  of culture  lysate  in phosphate-buffered saline, pH 7.0, 
there  was  added  0.5  ml.  of  a  1:5  dilution of  type III antipneumococcal horse  serum  1 
that had been absorbed with an extract of sonically disrupted R cells derived from type III 
pneumococcus, in order to remove antibody reacting with the somatic constituents of pneu- 
mococei.  2 After 60 minutes in a water bath at 37°C. the precipitate was resuspended by shak- 
ing and the optical density was read against a broth blank in a Beckman DU spectrophotom- 
eter at 650 m/~., employing microcells with a light  path of  1 cm. The optical  density was 
converted to micrograms SIII per milliliter by comparison with a standard curve prepared by 
use of a secondary standard of SIII having a purity of 60 per cent as compared with a highly 
purified preparation  of SIII (6). 
EXPERIMENTAL 
Transformation  to  Type  III  of Different  R  Strains  Derived from  Type  I 
Strain 519/43/41°.--Transformation  reactions were  carried  out  using trans- 
forming principle (TP) from a  fully encapsulated "normal" strain of type III 
pneumococcus, IIIS-A/66. The IR strains employed were selected from strain 
1-519/43/41  ° by growth in broth containing type I  antiserum. Five R  strains 
were streaked on the surface of blood agar plates. Twelve R  colonies, among 
them  I-R6  and I-RT,  were picked from  the  five strains,  replated  on blood 
agar and single colonies transferred to broth for use in transformation reac- 
tions. In the presence of the normal IIIS transforming principle, transformation 
to type III occurred readily with all of the IR strains that were tested. The 
transformed organisms from a  single transformation tube gave rise to colonies 
that varied in size but were smaller than colonies obtained by transformation 
1  Type III antipneumococcal horse serum was provided by the Bureau of Laboratories, 
New York City Department of Health. 
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of other R  strains,  such  as  R36NC,  with  extracts of  the normal  type IIIS 
strain. It should be noted that heretofore the IIIS colonies obtained by trans- 
formation reactions have resembled in size the colonies of the S organisms from 
which the transforming principle was prepared. 
Presence of Normal  Type  III  Transforming  Principle  in  Transformed  R 
Organisms That Formed Small HIS Colonies.--Because of the small size of the 
IIIS colonies produced by the IR strains that had been transformed to type 
III by a normal IIIS transforming extract, it was of interest to prepare extracts 
from these transformed strains to determine whether they contained the nor- 
mal type III transforming principle or whether an alteration had taken place 
in the principle upon residence and reduplication within the IR strains. 
TABLE I 
Presence of "Normal"  Transforming Principle in Cells Producing Small Amount of SIlI 
Size of colonies 
Source of type III transforming principle  R strain transformed  formed by trans- 
formed organisms 
IIIS-A66  (normal IIIS  strain) 
naturally occurring 
IIIS-IR6 (small colony) obtained 
by transformation 
E~  cl 
IIR36NC (normal R strain) 
I-R6 (atypical R strain) 
I-R7 (atypical R strain) 
IIR36NC (normal R strain) 
I-R6 (atypical R strain) 
I-R7 (atypical R strain) 
Large 
Small 
Small 
Large 
Small 
Small 
Normal IIIS transforming principle was applied to R  strains I-R6 and I-R7. 
Twenty-four hours later a  loopful of culture from each transformation tube 
was  streaked on blood agar and  after incubation 2  colonies of transformed 
organisms  from each of the  IR  strains  were selected. These  4  transformed 
strains of IR were then grown in broth and transforming extracts  prepared 
from each of them and applied to strains I-R6 and IoR7 and to a  strain  of 
IIR,  R36NC.  Table  I  shows  the  results  obtained  with  TP  prepared  from 
one of the transformed IR strains, and with TP from a normal strain of type 
IIIS. The results with the transforming principles from the other 3 transformed 
IR strains were identical with those shown in Table I  for strain IIIS-IR6. 
From the observations presented in Table I it is apparent that although the 
transformed IR strains produce small IIIS colonies, and have the appearance 
of organisms containing a  mutated transforming principle, nonetheless, they 
actually contain the normal IIIS  transforming principle, which, in the trans- 
formed IR  strains,  is  not  expressed phenotypically, but when applied  to a 
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to that resulting from application  of a TP derived from the normal strain of 
type III  (A56). 
The property  of producing  less  than  the normal  amount of SIII appears 
to be stable,  since cultures of transformed strain IIIS-IR6 in fluid or on solid 
medium maintain this characteristic upon repeated subculture and after mouse 
passage. 
Quantitative Measurement of Production of Type HI Polysacckaride by Normal 
and Transformed Strcn'ns.--In order to  prove that the size of the colonies  of 
the transformed IR organisms is due to a reduction in capsular polysaccharide 
TABLE  II 
Polysacch~r~de Production  of Normal  and  Transformed  SWains  Measured  after  Growth in 
Broth  at 37°C./or  8  Hours 
Strains of 
pneumococcus 
IIIS-A56 
IIIS-RB6NC 
IIIS-IR6 
IIIS-R36NC 
Description 
Naturally occurring nor- 
mal IIIS strain 
Transformed strain, Nor- 
mal  IIR  strain  trans- 
formed  by  TP  from 
IIIS-A66 
Transformed  strain.  IR 
strain  transformed  by 
TP  from  IIIS-A66 
Transformed strain. Nor- 
mal  IIR  strain trans- 
formed  by  TP  from 
IIIS-IR6 
Viable 
count/ml. 
2.4  X  108 
5.5  X  l0  s 
2.2  X  i0: 
1.5  X  lO  s 
* Volume of 18 hour broth culture causing death of mice. 
SIII/ml. Bacterial 
N/ml. 
/~g.  /~g. 
36.3  i0.0 
29.4  11.4 
7.86  6.6 
24.4  8.3 
~g. SIII/ 
~g. oac- 
terialN 
3.63 
2.58 
1.19 
2.94 
M OUS~ 
vlr11~ 
fence* 
mr. of 
culture 
10-s 
lO-S 
10-I 
10-8 
production per bacterial cell and not merely a  reflection of slower bacterial 
multiplication, the production of SIII was measured in young broth cultures 
after lysis  by  sodium  desoxycholate. These  measurements  are  recorded  in 
Table II. 
From Table II it can be seen that the transformed atypical IR strain (III- 
IR6) produced only one-third as much SIII per microgram bacterial N  as the 
fully encapsulated,  normal strain IIIS-A66,  and less  than one-half as much 
SIII as the transformed normal IIR strain. However, despite the small amount 
of SIII produced by the transformed strain IIIS-IR6, the transforming prin- 
ciple prepared from it confers on the normal IIR strain the capacity to produce 
as much SIII as does the TP from the normal type III strain. 
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IIR36NC as compared with the naturally occurring strain IIIS-A66 has been 
observed consistently in the present and in previous experiments. The differ- 
ence may depend upon technical factors, but more likely it is due to a lower 
ability of the transformed strain IIIS-IIR36NC to form polysaccharide even 
though it contains the normal IHS transforming principle. If the latter is the 
correct explanation,  then the markedly diminished capacity of strain IIIS- 
IR6 to form SIII is not so unique as might appear at first glance but represents 
rather an exaggeration of a defect which is also present in strain IIR36NC. 
In Table II is also shown the virulence for mice of the four strains. The 
three strains that produce large amounts of polysaccharide are highly virulent, 
whereas strain IIIS-IR6 which produces a  markedly reduced amount of SIII 
is avirulent. 
DISCUSSION 
The experiments reported in the present paper demonstrate that alterations 
in capsular polysaccharide formation by pneumococci may depend not only 
on the nature of the S transforming principle present in the cells hut also on 
cell factors distinct from the S transforming principle. 
In the case described the cells contain the "normal" transforming principle, 
yet synthesize only one-third to one-half as much SIII as would be expected 
if the transforming principle were the only determining influence, as had ap- 
peared to be the case from previous studies. The nature of these modifying 
factors is unknown but it may he suggested that the diminution in SIII pro- 
duction may be caused by deficiency in the formation of a component or com- 
ponents of the polysaccharide, or  to  the presence  of inhibitors of polysac- 
charide synthesis at some stage of its production. 
It has been shown (3) that the virulence of strains of type III pneumococci 
for mice is correlated with the quantity of SIII formed in v/tro. A similar rela- 
tionship was observed in the present experiments, even though the cause of 
the decreased SIII production differs from that previously reported. 
SUMMARY 
Pneumococci can possess the normal S transforming principle and yet pro- 
duce amounts of capsular polysaccharide much less  than would be expected 
if the quantity formed depended only on the nature of the S  transforming 
principle. 
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